Zobrazeno 1 - 8
of 8
pro vyhledávání: '"M. E. Holownia-Voloskova"'
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 2, Pp 22-29 (2021)
Objective: to review the data on the efficacy and consumption of octocog alfa and rurioctoctog alfa pegol in standard prophylaxis and individualized prophylaxis in hemophilia A patients based on published international data. Material and methods: a s
Externí odkaz:
https://doaj.org/article/d36975204b65479fb7c110928a23e0a0
Autor:
D. L. Klabukova, M. E. Holownia-Voloskova, M. V. Davydovskaya, T. N. Ermolaeva, K. I. Polyakova, A. G. Fisun, K. A. Kokushkin
Publikováno v:
Фармакоэкономика, Vol 11, Iss 3, Pp 43-56 (2018)
Aim: To analyze the efficacy, safety and pharmacoeconomic aspects of using ocrelizumab in adult patients with relapsing/remitting multiple sclerosis (R/R MS).Materials and Methods. We used the commonly accepted PICo(S) questionnaire with the followin
Externí odkaz:
https://doaj.org/article/b6bb58345cfa4156b4150af64aa8d7d3
Autor:
D. L. Klabukova, M. E. Holownia-Voloskova, M. V. Davydovskaya, T. N. Ermolaeva, E. M. Olyushina, K. I. Polyakova, A. G. Fisun, M. G. Grinin, K. A. Kokushkin
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 2, Pp 29-41 (2018)
Aim. To analyze the efficacy, safety and pharmacoeconomic indicators of ocrelizumab in adult patients with primary progressive multiple sclerosis (PPMS). Methods. An information search was conducted in the databases Embase, PubMed, Cochrane and eLibr
Externí odkaz:
https://doaj.org/article/aa4fd7a29f4e4e52af7f6484f7dcf4c5
Publikováno v:
Problems of Social Hygiene, Public Health and History of Medicine. 30:1004-1009
The article is a comparative analysis of the quality of life indicators of patients with rheumatoid arthritis with similar indicators in the Moscow population. We conducted a survey of patients in the register of rheumatoid patients in Moscow using t
Publikováno v:
Onkourologiâ, Vol 17, Iss 2, Pp 112-127 (2021)
Objective: to determine the economic and clinical consequences of using atezolizumab in metastatic urothelial cancer compared with pembrolizumab and nivolumab.Materials and methods. An assessment of the effectiveness and safety of medicines for uroth
Publikováno v:
Problemy sotsial'noi gigieny, zdravookhraneniia i istorii meditsiny. 29
Interest in chloroquine, and its analog with a more favorable safety profile - hydroxychloroquine, in 2020 is certainly associated with the outbreak of a new coronavirus infection, SARS-CoV-2. The high pathogenicity and lack of specific immunity in t
Autor:
K. A. Kokushkin, K. I. Polyakova, A. G. Fisun, M. E. Holownia-Voloskova, M. V. Davydovskaya, D. L. Klabukova, T. N. Ermolaeva
Publikováno v:
Фармакоэкономика, Vol 11, Iss 3, Pp 43-56 (2018)
Aim: To analyze the efficacy, safety and pharmacoeconomic aspects of using ocrelizumab in adult patients with relapsing/remitting multiple sclerosis (R/R MS).Materials and Methods. We used the commonly accepted PICo(S) questionnaire with the followin
Publikováno v:
Pharmacoeconomics: theory and practice. 6:45-45